APA (7th ed.) Citation

S, C., G, B., MH, H., M, P., A, A., M, M., . . . EA, T. (2026). Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients. Cardiovascular drugs and therapy, 40(3), 1001. https://doi.org/10.1007/s10557-025-07757-3

Chicago Style (17th ed.) Citation

S, Chunduri, et al. "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients." Cardiovascular Drugs and Therapy 40, no. 3 (2026): 1001. https://doi.org/10.1007/s10557-025-07757-3.

MLA (9th ed.) Citation

S, Chunduri, et al. "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients." Cardiovascular Drugs and Therapy, vol. 40, no. 3, 2026, p. 1001, https://doi.org/10.1007/s10557-025-07757-3.